CollPlant Biotechnologies Ltd.

Welcome to the Cold Plant Biotechnologies Investor Conference Call to discuss financial results for the second quarter of 2023 and corporate updates. At this time, all participants are on a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the call over to your host, Dori Kurowski of LifeSci Advisors.

Please go ahead.

I would like to welcome everyone to Coal Plant Biotechnology's Financial Results Conference Call for the second quarter ended June 30, 2023, and Corporate Business Update. With us on the call today from Coal Plant are Yigal Tal, Chief Executive Officer, who will provide an overview of the company's program and forthcoming updates. And Aran Rotem, Deputy CEO and Chief Financial Officer, who will provide a summary of Coal Plant's financial results for the second quarter ended June 30th, 2023. Before we get started, I would like to remind everyone that statements made on this conference call may include forward-looking statements. Actual events or results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties, and other factors, including those set forth in the Risk Factors section of COPLAN's filings with the Securities and Exchange Commission. These filings can be found at www.sec.gov or on COPLAN's website at www.coalplant.com. In addition, any forward-looking statements made on this call represent Coal Plant's views only as of today, August 24, 2023, and should not be relied upon as representing the company's views as of any subsequent date. Coal Plant Management specifically disclaims any obligation to update or revise any of these forward-looking statements. Finally, coal plant management will refer to certain financial measures not reported in accordance with GAAP on this call. You can find reconciliations of these non-GAAP financial measures to the GAAP financial measures in the earnings press release that Coal Plant published earlier today and which is available on Coal Plant's website at ir.coalplant.com. With that, let me turn the call over to Yahil Tal, Chief Executive Officer of Coal Plant Biotechnologies. Please go ahead, sir.